National Health Spending In 2014: Faster Growth Driven By Coverage Expansion And Prescription Drug Spending.
about
Reply.Overfat and Underfat: New Terms and Definitions Long OverdueThe Charter on Professionalism for Health Care OrganizationsTrends in medicines procurement by the Brazilian federal government from 2006 to 2013.Key Features of Academic Detailing: Development of an Expert Consensus Using the Delphi MethodThe Empirical Foundations of Telemedicine Interventions in Primary CareWhere Have All the Primary Care Doctors Gone?Food assistance is associated with decreased nursing home admissions for Maryland's dually eligible older adults.Comparing Medical Ecology, Utilization, and Expenditures Between 1996-1997 and 2011-2012.Longitudinal Patterns of Medication Nonadherence and Associated Health Care Costs.Adjusting the Measurement of the Output of the Medical Sector for Quality: A Review of the Literature.Early Performance in Medicaid Accountable Care Organizations: A Comparison of Oregon and Colorado.Analysis of Actual Versus Projected Medical Claims Under the First Year of ACA-Mandated Coverage.Adjusting Health Expenditures for Inflation: A Review of Measures for Health Services Research in the United States.Impact of a Value-based Formulary on Medication Utilization, Health Services Utilization, and Expenditures.Reducing branded prescription drug prices: A review of policy options.Branded prescription drug spending: a framework to evaluate policy options.Value: The Next Frontier in Cancer Care.Critical Lessons From High-Value Oncology Practices.Studying de-implementation in health: an analysis of funded research grants.The Prevalence of Overfat Adults and Children in the US.Minding Ps and Qs: The Political and Policy Questions Framing Health Care Spending.Characteristics of High- and Low-Efficiency Hospitals.Simulating Variation in Families' Spending across Marketplace Plans.MACRA and the future of value-based care.Promoting the Health of Families and Communities: A Moral Imperative.Design Challenges of an Episode-Based Payment Model in Oncology: The Centers for Medicare & Medicaid Services Oncology Care Model.Understanding Trends in Medicare Spending, 2007-2014.It's the Prices, Advanced Capitalism, and the Need for Rate Setting - Stupid.Medicaid Reimbursement for Oral Direct Antiviral Agents for the Treatment of Chronic Hepatitis C.Pharmacy Benefit Management Companies: Do They Create Value in the US Healthcare System?Fifty years of preventing and treating childhood behaviour disorders: a systematic review to inform policy and practice.
P2860
Q30275698-E435D53E-2983-46AF-9E2D-136E2CCF4DEAQ30397621-0F250049-D4F6-481F-A899-715D27A18D4CQ30490677-5CB19863-2310-47BA-A590-4204F4C566D5Q36339862-9F6984BC-C499-49DC-9CD2-89C4CF11B855Q36771593-23933B7E-F607-4711-8492-6793EDFF279AQ36881973-0CFF5DF5-2D04-4836-9A56-897B6D6B74F9Q37015235-C8D4AB92-71CB-4951-B5AF-CE75CCB17E4CQ38664237-B7317123-99CE-4566-B9FD-18DAD534FC1EQ38685432-FDD7C957-28CF-4DDF-9206-76BA81E4B2FDQ38724407-54760E73-94D3-4D22-8380-5748E75FF9D5Q38925564-81032342-4FA4-4B4D-9586-5E1C90F9BEC2Q38964010-3844A1B2-AF90-432E-BDF5-AA401813289AQ39011351-D27F58E2-A085-4443-8C34-106E52662E01Q39016355-B5352343-132D-436E-B6D8-56DDD53CF124Q39436298-E1C82F41-17B0-4048-B541-A2F31A3117EAQ40083993-3910E43A-E7C0-4DF7-94B7-D5016839CA9BQ42284328-1B0EC7D0-3552-44B0-A91E-C205D7DB6773Q42649907-0778C9FE-75BD-4632-82A4-CEB57C6DA23AQ46154867-C7D8E882-FBC7-4324-8C0F-99BF4E77E2FEQ47094162-FA2C94C4-5006-4AD4-9CD9-C4810F8084E9Q47107901-43B9520E-063A-4EE9-8539-855C463B682CQ47311890-D5A89F9D-AFEE-482D-B72F-D5440291F26FQ47573473-87C945E4-DA41-4686-9860-ADAD6FFE63BBQ49990696-DC5C2EBB-688C-4B62-96A0-FBD49F9D7D3AQ50007466-0F347555-860F-4A59-AB9E-00E2E39612DBQ50146226-E06ABCB3-771A-4351-8EA9-88AE1A48C8CCQ50629315-2EA55874-8540-4EED-AD2A-C438737FACD7Q51743605-4512FDDB-F12D-4282-9EB4-12F1426E8BE3Q51812869-D7C706DF-C570-4142-8786-D3D6E5B31CFFQ53381076-6356AB52-0E0D-4869-85CE-92E50A519FE2Q53657682-2E1E30D8-3E21-4407-9963-2DD74B2827D3Q55194919-054DAE51-6CF6-4620-9DD4-F895447BBC94
P2860
National Health Spending In 2014: Faster Growth Driven By Coverage Expansion And Prescription Drug Spending.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
National Health Spending In 20 ...... nd Prescription Drug Spending.
@en
type
label
National Health Spending In 20 ...... nd Prescription Drug Spending.
@en
prefLabel
National Health Spending In 20 ...... nd Prescription Drug Spending.
@en
P2093
P1433
P1476
National Health Spending In 20 ...... nd Prescription Drug Spending.
@en
P2093
Aaron Catlin
Anne B Martin
Joseph Benson
Micah Hartman
National Health Expenditure Accounts Team
P304
P356
10.1377/HLTHAFF.2015.1194
P407
P577
2015-12-02T00:00:00Z